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Background: Moderate-intensity exercise training improves skeletal muscle aerobic capacity and increased
oxidative enzyme activity, as well as exercise tolerance in COPD patients.
Methods: To investigate whether the home-based exercise training program can reduce inflammatory biomarkers
in patients with COPD, twelve patients using mobile phone assistance and 14 with free walk were assessed by
incremental shuttle walk test (ISWT), spirometry, strength of limb muscles, and serum C-reactive protein (CRP) and
inflammatory cytokines.
Results: Patients in the mobile phone group improved their ISWT walking distance, with decrease in serum CRP
after 2 months, and sustained at 6 months. Patients in the control group had no improvement. Serum IL-8 in the
mobile phone group was significantly reduced at 2, 3 and 6 months after doing home exercise training compared
to baseline. IL-6 and TNF-α were significantly elevated at 3 and 6 months in control group, while there were no
changes in mobile phone group. The strength of limb muscles was significantly greater compared to baseline at
3 and 6 months in the mobile phone group.
Conclusions: A mobile-phone-based system can provide an efficient home endurance exercise training program with
improved exercise capacity, strength of limb muscles and a decrease in serum CRP and IL-8 in COPD patients.
Decreased systemic inflammation may contribute to these clinical benefits. (Clinical trial registration No.: NCT01631019)
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Chronic obstructive pulmonary disease (COPD) is char-
acterized by irreversible airflow obstruction with chronic
airway inflammation and emphysematous changes in the
lung parenchyma [1,2]. The cardinal symptoms of COPD
are dyspnea and/or fatigue, which may result from ventila-
tory constraints, pulmonary gas exchange abnormalities,
peripheral muscle dysfunction, cardiac dysfunction, or
combination of the above. COPD is also characterized
by persistent chronic inflammation that may extend
beyond the pulmonary system, resulting in a state of* Correspondence: wchunhua@ms7.hinet.net
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unless otherwise stated.persistent low grade systemic inflammation [2,3] which
has been implicated in various co-morbidities of COPD
[4,5]. These extrapulmonary manifestations contribute
to morbidity and mortality in COPD patients.
Several systemic inflammatory markers or cytokines in-
cluding C-reactive protein (CRP), IL-6, IL-8, and tumor
necrosis factor (TNF)-α have been associated with COPD
risk, COPD mortality, COPD exacerbations, or lung func-
tion decline [6-9]. Serum CRP may provide prognostic
information about morbidity and mortality in mild to
moderate COPD [7,8] with relationships between CRP,
IL-6, exercise tolerance, and health status [8,10]. Systemic
IL-6 levels are inversely correlated with FEV1, and quad-
riceps strength is independently associated with reduced
exercise tolerance [11,12]. IL-8 and TNF-α may be im-
portant signaling molecules for neutrophil activation.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Table 1 Characteristics of patients with chronic
obstructive pulmonary disease (COPD)
Control Mobile phone P-
value(N = 14) (N = 12)
Age, yrs 71.9 ± 2.7 71.4 ± 1.9 0.890
Gender, male 14 12 1.000
Body mass index, kg/m2 24.5 ± 0.7 22.4 ± 1.0 0.094
SGRQ score 38.1 ± 4.2 32.0 ± 4.0 0.307
Walking distance (ISWT), M 251.4 ± 21.0 261.5 ± 29.9 0.782
FVC, L 1.9 ± 0.1 2.2 ± 0.2 0.158
FVC, % pred. 58.2 ± 4.2 67.5 ± 4.9 0.163
FEV1, L 1.2 ± 0.2 1.5 ± 0.2 0.285
FEV1, % pred. 54.2 ± 6.7 63.5 ± 7.0 0.349
FEV1/FVC, % 63.4 ± 2.9 64.9 ± 4.6 0.784
IC before ISWT, L 1.2 ± 0.1 1.2 ± 0.1 0.731
IC after ISWT, L 1.2 ± 0.1 1.2 ± 0.1 0.615
Delta IC* −0.04 ± 0.1 −0.05 ± 0.1 0.815
Definition of abbreviations: ISWT = incremental shuttle walk test; SGRQ = San
George Respiratory questionnaire; FEV1 = forced expiratory volume in 1 s;
FVC = forced vital capacity; IC = inspiratory capacity* Change in inspiratory
capacity on exercise
Data expressed as mean ± SE.
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ported during exacerbations of COPD [13]. Elevated levels
of IL-8 have been found in the bronchoalveolar lavage fluid
of smokers and COPD patients that correlated positively
with neutrophil counts [14]. Circulating levels of IL-8 are
elevated during acute COPD exacerbations [15], which
contribute to a reduction in health-related quality of life
[16]. TNF-α and IL-6 are acute phase proteins known to
upregulate the synthesis of CRP, and fibrinogen [17]. The
distance walked in the 6-minute walk test was inversely
related to serum CRP, IL-6 and IL-8 levels in COPD pa-
tients [9]. Taken together, these data suggest that systemic
inflammation related to COPD may in part be related
to the reduced muscle strength and exercise tolerance
observed in COPD patients.
Exercise training is the cornerstone of comprehensive
rehabilitation programs in COPD [1]. It improves skeletal
muscle oxidative capacity and efficiency with reduced
alveolar ventilation at a given work rate [18,19], leading to
tolerance of a heavier work load with less dyspnea [20].
Endurance exercise training is clinically efficacious [21]. A
recent review supports the notion that mobile technology
is a promising way of delivering health services and
enhances the exercise training program of pulmonary
rehabilitation [1]. Most pulmonary rehabilitation programs
are hospital-based and rely on regular supervision and
monitoring to achieve persistent and optimal physiological
benefits. However, compliance is a major stumbling block
[22]. We have developed a home-based exercise training
program for stable COPD patients by asking them to walk
at a speed controlled by the tempo of music from a pro-
gram installed on a mobile phone [23]. This system provides
an efficient home endurance exercise training program with
good compliance and clinical outcomes in patients with
moderate-to-severe COPD [23]. We further explored
whether the circulating levels of inflammatory markers,
such as CRP, IL-6, TNF-α, and IL-8 will be reduced in
patients with COPD undergoing a mobile-phone assisted
home-based exercise training program [23].
Methods
Study subjects
Thirty patients with diagnosis of COPD [with a ratio of
forced expiratory volume in one second (FEV1) to forced
vital capacity (FVC) less than 0.7 after bronchodilators]
who had the grading of moderate-to-severe airflow limi-
tation according to GOLD criteria [24] were recruited
(Table 1). All subjects were stable within three months
prior to enrollment. Exclusion criteria included require-
ment for oxygen therapy (because these patients were
known to be difficult to keep up with mobile-based exer-
cise program) and presence of symptomatic cardiovascu-
lar diseases or severe systemic diseases (i.e. hematologic
disease, malignancy, systemic lupus erythrosis, end stagerenal disease and severe liver cirrhosis) or musculo-
skeletal conditions with exercise performance limitation.
The patients had received regular hospital-based re-
habilitation training program once per week, including
negative lung expansion therapy, and bicycle riding
training, in a clinical stable status at least 3 months.
Patients were randomized into either the mobile-phone
(n = 14) or the control group (n = 16), and stopped their
regular hospital-based rehabilitation program at entry.
Two patients of the mobile-phone group and one in
control group withdrew because of personal reasons,
and one was unwilling to continue after an acute exa-
cerbation. The study was approved by Chang Gung
Memorial Hospital Ethics Committee. Written informed
consent was obtained from all subjects.
Study design
Initially, all subjects were assessed by an incremental
shuttle walking test (ISWT) [25] after practice. Patients
in the mobile phone group performed daily endurance
exercise training under mobile phone guidance, and ad-
herence was reported back to the central server. To en-
sure subject adherence to the exercise program, at least
one health-care member or family learned how to use
the exercise program instilled into phone. They opened
the mobile phone or helped the patient to answer three
questions to confirm successful connection. Then, they
got a message from the center server automatically to
ensure that the exercise started to be recorded. To ex-
clude the people who may have listened to music but
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ber or family helped or witnessed the patients to
undergo the mobile phone exercise program each time.
Endurance walking level was re-assessed and re-adjusted
initially on regular clinical visits every four weeks during
the first three months. Adherence was reinforced by
telephone from health professionals whenever patients
missed one day of training. Patients continued their ex-
ercise program at home at a fixed walking speed, and
returned to the clinic at 1, 2, 3 and 6 months. Adherence
to the home-based exercise training program was
assessed on the central system every week. Patients in
the control group were taught the same exercise protocol,
but were verbally encouraged to take walking exercise
training at home without any telephone reinforcement.
Adherence to the home walking exercise was self-reported.
ISWT and venous blood sample for inflammatory bio-
markers were performed at baseline, 1, 2, 3 and 6 months.
Endurance walking exercise with constant intensity
The walking speed of the endurance exercise training at
home was set at 80% of maximal capacity predicted from
the distance walked during the ISWT [23]. Using the
equationofPredictedVO2peak (ml/min/kg)=4.19+(0.025 ×
ISWT distance), the peak oxygen uptake (VO2peak) of
ISWT could be estimated. The level representing 80% of
the maximal capacity for endurance walking training at
home was derived from 80% of the predicted VO2peak
value [25]. Patients took another endurance shuttle
walk at this calculated level. The number of steps per
shuttle was counted. The tempo of music for the
appropriate walking speed was calculated based on the
walking speed and the number of steps per shuttle accor-
ding to the equation: Tempo (beats per minute) = speed
(km/h) × 100 × steps per shuttle ÷ 60. Patients then followed
this individualized music tempo to walk at a constant
speed. The software used for mobile phone monitoring
was a Java based application (Java 2 Micro Edition,
J2ME) and also provided the music tempo.
Home-based endurance exercise training
The music software with an individualized preset tempo
was installed onto the patients’ mobile phones. Patients
turned on the program to walk at a speed following the
tempo of music on the mobile phone. Patients turned
off the program on the mobile phone when they could
not catch up with the tempo. The mobile phone
recorded the duration of music played (equal to the
duration of walking), and the information was automa-
tically sent to the website server by GPRS for storage.
Measurements of pulmonary function tests
Forced vital capacity (FVC), forced expiratory volume in
one second (FEV1), FEV1/FVC ratio, inspiratory capacity(IC) and breathlessness (rated by Borg’s scale) were mea-
sured before and immediately after the ISWT at each
hospital visit at 1, 2, 3 and 6 months.
Measurements of muscle strength
The elbow flexor and knee extensor muscle groups were
assessed using a handheld dynamometer microFET2
(Hogan Health Industries, Inc, Draper, UT) [26]. The
isometric force of the elbow flexors was assessed with
the elbow flexed 90 degrees. The strength of knee exten-
sor muscle was measured with the subject seated with
the leg fully extended. Strength was recorded as the peak
force of three tests.
Measurements of CRP, IL-6, IL-8 and TNF-α
Venous blood samples were collected at the same time
of day before the exercise training and at baseline, 1, 2, 3
and 6 month. The serum was kept in –70°C freezers.
The levels of CRP, IL-6, IL-8 and TNF-α were measured
by using highly sensitive enzyme linked immunosorbent
assay kits (Alpha Diagnostics, San Antonio, TX, USA).
The median interassay coefficient of variation was 6.3%.
Statistical analysis
Data were presented as mean ± SE. The baseline data of
the mobile phone and the control group were evaluated
by descriptive statistics and analyzed by Student's test.
The data of the mobile phone group and the control
group or between the two groups from baseline to 6
months were determined by analysis of variance with
repeated measures. A p value < 0.05 was considered
significant.
Results
The two groups were comparable in terms of the sever-
ity of COPD (Table 1). The subjects in mobile-phone
group performed walking exercise at home at a fre-
quency of around 4 to 6 days per week throughout the 6
months. Only 50% of patients (n = 7) in control group
reported by themselves that they still kept regular walk-
ing at the end of study.
Walking distance under ISWT
In the mobile phone group, there was an improvement
in walking distance at 3 months (310.8 ± 34.0 M, n = 12,
p < 0.05), and at 6 months (320.0 ± 30.7 M, n = 12, p < 0.01)
compared to the baseline (261.5 ± 29.9 M, n = 12, analysis
of variance with repeated measures) (Figure 1). However, in
the control group, walking distance (251.4 ± 21.0 M, n =
14, baseline) was going down over time (222.5 ± 28.3 M,
n = 14, at 6 months), but no significance was achieved
(Figure 1). The walking distance of the mobile phone
group was significantly increased compared to the control
group at 3 and 6 months.
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The strength of the 4 tested upper and lower extremity
muscle groups were the same at baseline in both groups
(Table 2). The muscle strength of both upper extremities
increased in the mobile phone group (p < 0.01) at the
second, third and sixth months compared with baseline.
After 3 and 6 months of mobile phone-based home walk
training, the strength of lower limb muscles was signifi-
cantly greater compared to baseline. The strength of
lower limb muscle in the mobile phone group was sig-
nificantly greater than that of the control group. In con-
trast, the strength of upper or lower limb muscle in the
control group did not show any change throughout the
study period compared with baseline.
Serum CRP, IL-6, IL-8 and TNF-α
Plasma levels of CRP in mobile phone group were
decreased after 2 months (975.3 ± 197.3 μg/ml, n = 12,
p < 0.05), 3 months (788.3 ± 237.0 μg/ml, n = 12,
p < 0.01) throughout 6 months (601.1 ± 144.5 μg/ml, n = 12,
p < 0.01) compared to baseline (1531.0 ± 206.4 μg/ml,
n = 12, analysis of variance with repeated measures).
Levels of CRP were increased at 3 months (2181.0 ± 352.5
μg/ml, n = 14) and 6 months (2080.0 ± 428.4 μg/ml,
n = 14) compared to baseline (1028.0 ± 213.1 μg/ml,
n = 14, p < 0.001, analysis of variance with repeated
measures) in the control group (Figure 2). PlasmaFigure 1 Incremental shuttle walking test (ISWT) was
performed in the mobile phone group (N = 12) and the control
group (N = 14) at baseline and after 1, 2, 3, 6 months. The
sample size was 12 in the mobile phone group and 14 in the
control group at each time point. Results are shown as mean ± SE.
*P < 0.05, **P < 0.01 compared to the baseline. #P < 0.05 compared
to the control group.levels of CRP in the control group were significantly
increased compared to the mobile phone.
Plasma levels of IL-8 in mobile phone group was sig-
nificantly reduced at 2 months (1196.0 ± 183.1 pg/ml,
n = 12, p < 0.05), 3 months (1179.0 ± 186.2 pg/ml, n = 12,
p < 0.01), through 6 months (990.1 ± 175.6 pg/ml, n = 12,
p < 0.01) on home exercise training compared to the
baseline (3299.0 ± 839.4 pg/ml, n = 12). The circulating
levels of IL-8 did not change (Figure 3). In the control
group at 6 months, plasma levels of IL-8 in the control
group were higher compared to the mobile group.
Levels of TNF-α did not show any difference during the
period of home exercise training program in the mobile
phone group (Figure 4A). By contrast, they were signifi-
cantly elevated at 2, 3 and 6 months in the control group
(Figure 4A). Serum levels of IL-6 was increased at 3
months (8.9 ± 2.3 pg/ml, n = 14, p < 0.001) and 6 months
(7.0 ± 1.0 pg/ml, n = 14, p < 0.05) compared to the baseline
(2.8 ± 0.5 pg/ml, n = 14), while levels of IL-6 in the
mobile phone group remained unchanged (Figure 4B).
Discussion
We demonstrated that COPD patients, under the assis-
tance of a mobile phone, were able to perform a home-
based, individualized endurance exercise training pro-
gram at an intended walking speed controlled by a
pre-set tempo of music. During the six month follow-up
period of home-based exercise training, exercise ca-
pacity, strength of limb muscles and inflammatory bio-
markers of CRP and IL-8 were improved in the group
under mobile phone guidance, but not in control group.
In control group, who did not benefit from regular
home-exercise training in the COPD patients, the level
of proinflammatory cytokines of IL-6 and TNF-α
remained elevated at 3 and 6 months. Our work indi-
cates for the first time that long-term home exercise
training using an individualized design and adjusted
training protocol can reduce the inflammatory bio-
markers, CRP and IL-8, which is likely the result of an
improvement in systemic inflammation.
CRP is an acute-phase reactant that can be upregu-
lated sensitively during systemic inflammation, and is as-
sociated with muscle mass, strength, physical function,
and disability [27]. CRP levels can be reduced in healthy
subjects receiving 9 months of endurance exercise train-
ing [28]. Increased concentrations of CRP and IL-6 were
associated with impaired physical function in older
adults with COPD [29]. In the control group, there was
a gradual increase in levels of proinflammatory cyto-
kines, IL-6, TNF-α and CRP in patients who performed
home exercise training of free walk. COPD patients are
likely to become de-conditioned gradually due to dys-
pnea and systemic inflammation [30], and may therefore
show significant cytokine response at low levels of
Table 2 Evaluation of limb muscle strength
Baseline 1 M 2 M 3 M 6 M ap
Control group n = 14 n = 14 n = 14 n = 14 n = 14
Elbow flexion, kg
Left 13.3 ± 0.7 12.2 ± 0.7 12.6 ± 0.5 13.0 ± 0.6 13.1 ± 0.5 0.354
Right 13.6 ± 0.8 12.4 ± 2.9 13.0 ± 0.5 13.3 ± 0.7 13.2 ± 0.6 0.953
Knee extension, kg
Left 12.2 ± 0.9 10.5 ± 0.7 12.6 ± 0.8 12.8 ± 0.6 12.8 ± 0.6 0.098
Right 12.0 ± 0.8 10.5 ± 0.7 12.2 ± 0.7 12.7 ± 0.6 12.7 ± 0.6 0.114
Mobile phone group n = 12 n = 12 n = 12 n = 12 n = 12
Elbow flexion, kg
Left 11.8 ± 0.5 12.4 ± 0.6 12.9 ± 0.5* 13.3 ± 0.5** 13.5 ± 0.5** 0.015
Right 11.5 ± 0.6 12.6 ± 0.5 13.5 ± 0.4* 14.3 ± 0.5*** 14.7 ± 0.4*** <0.001
Knee extension, kg
Left 10.9 ± 0.8 11.8 ± 0.8 12.3 ± 0.7 13.7 ± 0.9 14.7 ± 0.7*# 0.016
Right 10.8 ± 0.8 11.5 ± 0.7 12.0 ± 0.8 13.9 ± 0.9* 15.1 ± 0.7**# 0.002
Definition of abbreviations: M, month; kg, kilogram. Data present as mean ± SE.
aP value was determined by analysis of variance with repeated measures.
*P < 0.05, **P < 0.01, ***P < 0.001 compared to the baseline of corresponding group. #p < 0.05 compared to the control group at the same time.
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effects [31]. Our previous study showed that under the
mobile-phone assisted home exercise training program
has improved exercise capacity, breathlessness, quality of
life, inspiratory capacity and air-trapping in patients with
COPD [23]. In this study, we extend further the benefits
of this program by showing that the strength of upper
and lower limb muscles in COPD patients increased
after 2 or 3 month of regular exercise. Thus, a mobileFigure 2 Plasma levels of C-reactive protein (CRP) were measured
in the mobile phone group and control group at baseline, 1, 2, 3
and 6 months. The sample size was 12 in the mobile phone group
and 14 in the control group at each time point. *P < 0.05,
**P < 0.01, ***P < 0.001compared with the baseline level of
corresponding group. #P < 0.05 compared to the control group.phone-based home exercise training program can pro-
vide an effective training for COPD patients. Long-term
exercise training can improve systemic inflammatory
biomarkers in patients with COPD.
The presence of systemic inflammation has been sug-
gested by studies [32,33] showing systemic oxidative
stress, the activation of circulating neutrophils and lym-
phocytes, and increased plasma levels of TNF-α. The
presence of oxidative stress in the airways of smokersFigure 3 Plasma levels of interleukin (IL)-8 were measured at
baseline, 1, 2, 3 and 6 months in the mobile phone group
(n = 12) and the control group (n = 14). *P < 0.05, **P < 0.01
compared to the baseline level of the mobile phone. #P < 0.01
compared to the control group at the same time point.
Figure 4 Plasma levels of (A) tumor necrosis factor (TNF)-α and (B) interleukin (IL)-6 were measured at baseline, 1, 2, 3, 6 months in both
groups. The sample size was 12 in the mobile phone group and 14 in the control group at each time point. *P < 0.05, **P < 0.01 ***p < 0.001
compared to the baseline levels of the control group.
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products of lipid peroxidation and altered antioxidant
status [34]. Transcription factors such as nuclear factor-
κB (NF-κB) and activator protein-1 (AP-1), which are
oxidant-sensitive, are important for gene transcription of
the inflammatory cytokines, and associated with upre-
gulated airway inflammation in COPD. Proinflammatory
cytokines, such as IL-8, TNF-α and IL-6 [34,35] are
oxidant-sensitive proteins. For example, IL-8 gene has
both NF-kB and AP-1 binding sites in the promoter
region that regulates its transcriptional activation [36].
Exercise training improves skeletal muscle oxidative ca-
pacity and efficiency that leads to less alveolar ventila-
tion for a given work rate [18,19]. Patients can tolerate a
heavier work load with less dyspnea on exercise [37].
The lower limb muscles play an important role in exer-
cise training programs because the quadriceps muscles
are the major muscles for patients’ mobilization [38]. In
our study, the upper limb muscles also benefit from the
paced-walk exercise training program, possibly related to
the coordinated training high-intensity exercise with
swing and balance of upper limbs.
Our results demonstrated that the serum levels of
TNF-α and IL-6 were increased in the control group.
The effects of peripheral muscle training on specific sys-
temic inflammatory mediator levels (TNF-α, IL-6 and
CRP) have been proposed to be associated with muscle
dysfunction in COPD [39,40]. Endurance exercise train-
ing in COPD can induce peripheral muscle adaptation
and modification by factors regulating skeletal muscle
hypertrophy and regeneration [41], but in the absence of
a decrease in systemic or local muscle TNF-α and IL-6,
similar to our results in the mobile phone group. In
addition, people with COPD who walked the most had
the lowest plasma CRP and IL-6 levels [42]. The systemic
inflammatory process, evaluated by serum IL-6 and TNF-
α which may result from pulmonary inflammation andoxidative stress or hypoxia [40,43], seems to be persistent
and progressive in COPD patients [42,44]. In our study,
COPD patients in the control group may have less inten-
sity of endurance walking training after stopping regular
hospital-based pulmonary rehabilitation. They exhibited s
raised plasma levels of TNF-α and IL-6 at 3 and 6 months
compared to those in the mobile phone group. TNF-α
and IL-6 are acute phase proteins known to upregulate
the synthesis of CRP and fibrinogen [17]. TNF-α activates
the transcription factor, nuclear factor-κB (NF-κB), that
switches on transcription of the IL-8 gene and increases
IL-8 release from the airway epithelium and neutrophils
[36]. Our results also showed a significant increase in
serum levels of CRP (at 3 and 6 months) and IL-8 (at 6
months) compared to the mobile phone group. These
results provide the conceptual basis that walking leads to
a reduction in systemic inflammation in COPD patients.
In the control group, one would expect that the walk-
ing distance may not be going up at the same rate as the
intervention group, but would hopefully at least remain
static than decline at 6 months. This finding had been
reported in the control group of Wijkstra et al [45]. One
possibility is that all subjects in our control group re-
ceived regular hospital-based rehabilitation of bicycling
training once per week, which can successfully maintain
functional exercise capacity [46]. Without a supervised
intervention, subjects of control group may decrease the
time or intensity of home walking program. Therefore,
their incremental shuttle walk distance only declined
gradually. 6MWT is a self-paced walking test of fixed
distance, while ISWT is a paced test of an indefinite du-
ration. The presence of quadriceps muscle fatigue was
more frequent and more pronounced after cycling than
after walking. Another possibility is that the incremental
shuttle walk in our study is more responsive to the ef-
fects of pulmonary rehabilitation than 6 minute walk
test (6MWT) [47]. In another study [48], the walking
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ping pulmonary rehabilitation program.
Exercise training is the cornerstone of pulmonary re-
habilitation [1,11]. High intensity training significantly
improved patients’ exercise capacity and physiologic
adaptation during endurance training [49]. COPD pa-
tients presented with increased pulmonary and systemic
oxidative stress after simple exercise compared with
healthy control subjects [50]. Unplanned exhausted exer-
cise in COPD patients may lead to fatigue and contri-
bute to exercise limitation related to the excessive load
placed on inspiratory muscles, and deteriorate systemic
inflammation [51]. Through well-designed evaluation of
patients’ exercise capability, our mobile phone based
program provides a real-time monitoring about patients’
daily exercise training, and dyspnea sensation. The
central monitoring of patients’ physical activity offers
the opportunity for early intervention and management
in COPD patients to prevent exacerbation of disease.
This specific computer-based monitoring strategy may
further reduce the medical costs through the planned
exercise training which reduced systemic inflamma-
tion, and improved patients’ adherence through daily
communication.
A randomized clinical trial showed that weekly tele-
phone contacts and monthly supervised rehabilitation
sessions produced only modest effects in maintaining
improvements in exercise tolerance and ratings of over-
all health status [52]. The exercise tolerance declined
gradually in the usual care group. In contrast, distance
walked on the endurance shuttle waking test (ESWT)
significantly improved either in the hospital or commu-
nity rehabilitation groups. There was no difference in ex-
ercise tolerance between hospital or community groups
with the telephone and no-telephone groups [53]. Our
work showed a greater improvement of exercise in
COPD patients by mobile phone home-based exercise
program. Effectiveness of intervention or contact or
combined with an optimal method, such as cell phone,
for incorporating rehabilitation strategies may have been
critical in motivating participants to continue exercise.
The present study indicates that COPD patients can
substantially benefit from rehabilitation with lower sys-
temic inflammation, even though hospital based exercise
training once per week. Several home-based rehabilita-
tion programs have been developed with proven clinical
benefits in quality of life and exercise tolerance [54,55].
In those programs for which walking freely for a period
of time is recommended, it is more difficult to establish
the walking speed necessary to achieve a training effect
at home [56]. The long-term adherence to exercise train-
ing is the critical factor in sustaining the clinical benefit
in the home setting program. It declines when regular
monitoring or supervision is removed [57], like ourcontrol group with progressive elevation of cytokines.
The current cell phone-assisted system may provide an
efficient home-based exercise training program, due to
its controlled exercise workload by pacing walking and
web-based supervision of exercise performance and
low-grade systemic inflammation.
The limitations of this study are its relatively small pa-
tient numbers, and short-term follow-up period. However,
these results demonstrate that intensive daily exercise pro-
grams without undue exhaustion can be performed suc-
cessfully on an out-patient basis through a mobile phone
based communication. This tele-rehabilitation program
combined the advantage of both the self-management
strategies and the direct investigation from the health care
groups via computer monitoring. Further longitudinal
observation for outcomes which includes decline in
pulmonary function, deterioration in muscle endurance,
as well as the systemic inflammatory mediators may lead
to useful measures to overcome detrimental changes in
COPD patients.Conclusions
Mobile-phone-based system provides a feasible, efficient
home paced-walk endurance exercise training program
with good compliance and clinical outcomes in improv-
ing exercise capacity, strength of limb muscles and redu-
cing inflammatory biomarkers, such as CRP and IL-8, in
patients with COPD. The improved systemic inflamma-
tion may contribute to clinical benefits such as a reduc-
tion in acute exacerbation. Exercise training tailored to
address the individual patient factor to optimal exercise
loading and intensity via surveillance through mobile
phone communication could play an important role in
optimising long-term outcomes and prevent functional
derangement in COPD patients.
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